Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms

被引：1
|
作者：
Cossins, J. [1 ]
Lashley, D. [1 ]
Spearman, H. [1 ]
Maxwell, S. [1 ]
Palace, J. [2 ]
Robb, S. [3 ]
Beeson, D. [1 ]
机构：
[1] Univ Oxford, Neurosci Grp, Weatherall Inst Mol Med, Oxford OX1 2JD, England
[2] John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England
[3] Great Ormond St Hosp Sick Children, Dubowitz Neuromuscular Ctr, Inst Child Hlth, London, England
来源：
NEUROMUSCULAR DISORDERS | 2010年 / 20卷
关键词：
D O I：
10.1016/S0960-8966(10)70066-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [21] Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes
    Mueller, Juliane S.
    Herczegfalvi, Agnes
    Vilchez, Juan J.
    Colomer, Jaume
    Bachinski, Linda L.
    Mihaylova, Violeta
    Santos, Manuela
    Schara, Ulrike
    Deschauer, Marcus
    Shevell, Michael
    Poulin, Chantal
    Dias, Ana
    Soudo, Ana
    Hietala, Maria
    Aarimaa, Tuula
    Krahe, Ralf
    Karcagi, Veronika
    Huebner, Angela
    Beeson, David
    Abicht, Angela
    Lochmueller, Hanns
    BRAIN, 2007, 130 : 1497 - 1506
  • [22] DOK7 Promotes NMJ Regeneration After Nerve Injury
    Kosco, Ethan. D. D.
    Jing, Hongyang
    Chen, Peng
    Xiong, Wen-Cheng
    Samuels, Ivy. S. S.
    Mei, Lin
    MOLECULAR NEUROBIOLOGY, 2023, 60 (03) : 1453 - 1464
  • [23] Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia
    Julien Oury
    Wei Zhang
    Nadia Leloup
    Akiko Koide
    Alexis D. Corrado
    Gayatri Ketavarapu
    Takamitsu Hattori
    Shohei Koide
    Steven J. Burden
    Nature, 2021, 595 : 404 - 408
  • [24] Functional characterisation of a mouse model of DOK7 congenital myasthenic syndrome and response to treatment with salbutamol
    Webster, R. G.
    Vanhaesebrouck, A. E.
    Maxwell, S. E.
    Cossins, J. A.
    Beeson, D. M. W.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S26 - S27
  • [25] A mutation in DOK7 in congenital myasthenic syndrome forms aggresome in cultured cells, and reduces DOK7 expression and MuSK phosphorylation in patient-derived iPS cells
    Zhang, Shaochuan
    Ohkawara, Bisei
    Ito, Mikako
    Huang, Zhizhou
    Zhao, Fei
    Nakata, Tomohiko
    Takeuchi, Tomoya
    Sakurai, Hidetoshi
    Komaki, Hirofumi
    Kamon, Masayoshi
    Araki, Toshiyuki
    Ohno, Kinji
    HUMAN MOLECULAR GENETICS, 2023, 32 (09) : 1511 - 1523
  • [26] Germline mutation in DOK7 associated with fetal akinesia deformation sequence
    Vogt, J.
    Morgan, N. V.
    Marton, T.
    Maxwell, S.
    Harrison, B. J.
    Beeson, D.
    Maher, E. R.
    JOURNAL OF MEDICAL GENETICS, 2009, 46 (05) : 338 - 340
  • [27] Interactions of Dok7 with Model Membranes Containing Anionic Lipids and Phosophoinositides
    Buyan, Amanda
    Kalli, Antreas C.
    Sansom, Mark S. P.
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 381A - 381A
  • [28] Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation
    Lorenzoni, Paulo J.
    Scola, Rosana H.
    Kay, Claudia S. K.
    Filla, Luciane
    Miranda, Anna P. P.
    Pinheiro, Joao M. R.
    Chaouch, Amina
    Lochmueller, Hanns
    Werneck, Lineu C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 331 (1-2) : 155 - 157
  • [29] DOK7 expression in colorectal cancer cells and association with patient survival
    Satherley, L.
    Ye, L.
    Hargest, R.
    Jiang, W. G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S158 - S158
  • [30] EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
    Lashley, D.
    Beeson, D.
    Jayawant, S.
    Palace, J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11):
12345